China Biotech Services Holdings Limited reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was HKD 51.8 million compared to HKD 302.82 million a year ago. Net loss was HKD 15.11 million compared to net income of HKD 33.28 million a year ago. Basic loss per share from continuing operations was HKD 0.016 compared to basic earnings per share from continuing operations of HKD 0.035 a year ago.
For the six months, sales was HKD 182.36 million compared to HKD 686.91 million a year ago. Net loss was HKD 30.48 million compared to net income of HKD 68.22 million a year ago. Basic loss per share from continuing operations was HKD 0.032 compared to basic earnings per share from continuing operations of HKD 0.071 a year ago.